Currently out of the existing stock ratings of Michael Okunewitch, 26 are a BUY (96.3%), 1 are a HOLD (3.7%).

Michael Okunewitch

Work Performance Price Targets & Ratings Chart

Analyst Michael Okunewitch, currently employed at MAXIM GROUP, carries an average stock price target met ratio of 8.04% that have a potential upside of 45.02% achieved within 100 days. Previously, Michael Okunewitch worked at BARCLAYS.

Michael Okunewitch’s has documented 52 price targets and ratings displayed on 8 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on HCWB, HCW Biologics at 28-May-2026.

Wall Street Analyst Michael Okunewitch

Analyst best performing recommendations are on ANEB (ANEBULO PHARMACEUTICALS).
The best stock recommendation documented was for ANEB (ANEBULO PHARMACEUTICALS) at 5/15/2025. The price target of $3 was fulfilled within 69 days with a profit of $1.99 (197.03%) receiving and performance score of 28.56.

Average potential price target upside

ATAI ATAI Life Sciences BV CTXR Citius Pharmaceuticals KPRX Kiora Pharmaceuticals BRTX BioRestorative Therapies ANEB Anebulo Pharmaceuticals CMMB Chemomab Therapeutics Ltd DRC HCWB HCW Biologics LGVN Longeveron LLC

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 01-Sep-2021

$7.5

$0.15 (2.04%)

$10

1 months 29 days ago
(17-Jul-2026)

1/5 (20%)

$0.28 (3.88%)

406

Buy Since 13-Jul-2021

$8

$0.65 (8.84%)

$17

1 months 30 days ago
(16-Jul-2026)

0/8 (0%)

$0.85 (11.89%)

Buy Since 09-Mar-2026

$14

1 months 30 days ago
(16-Jul-2026)

0/2 (0%)

$10.11 (259.90%)

Buy Since 19-Oct-2021

5 months 29 days ago
(17-Mar-2026)

0/8 (0%)

$9.51 (173.22%)

Buy Since 29-Jul-2025

$16

$10.71 (202.46%)

$14

1 years 1 months 14 days ago
(01-Aug-2025)

0/2 (0%)

$11.83 (283.69%)

Show more analysts

Please expand the browser size to see the chart

Which stock is Michael Okunewitch most bullish on?

Potential upside of $2.76 has been obtained for HCWB (HCW BIOLOGICS)

Which stock is Michael Okunewitch most reserved on?

Potential downside of -$0 has been obtained for LGVN (LONGEVERON LLC)

What Year was the first public recommendation made by Michael Okunewitch?

On 2021

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?